# Efficacy and tolerability of adding prescription Omega-3 fatty acids 4 g/d to Simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-controlled study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-tolerability-of-adding-prescription-omega-3-fatty-acids-4-g-d-to/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Michael H. Davidson,Evan A. Stein,Harold Bays,Kevin C. Maki,Ralph T. Doyle,Robert A. Shalwitz,Christie M. Ballantyne,Henry N. Ginsberg |
| Citations | 388 |
| DOI | 10.1016/j.clinthera.2007.07.018 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2132010550 |
| PMID | 17825687 |
| Type | article |
| Year | 2007 |

## Paper authors

- [Kevin C. Maki](https://scholariq.org/researchers/kevin-c-maki/)

## Paper journal

- [Clinical Therapeutics](https://scholariq.org/journals/clinical-therapeutics/)

## Paper primary topic

- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)

## Paper topics

- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Lipid metabolism and disorders](https://scholariq.org/topics/lipid-metabolism-and-disorders/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.